Stifel initiates coverage on Tango Therapeutics with a Buy rating and $15 PT.

jueves, 4 de diciembre de 2025, 12:01 pm ET1 min de lectura
TNGX--

Stifel initiates coverage on Tango Therapeutics with a Buy rating and $15 PT.

Stifel initiates coverage on Tango Therapeutics with a Buy rating and $15 PT.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios